Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 16,014 | 14,334 | 15,020 | 13,645 | 15,428 |
| Operating Income | -16,014 | -14,334 | -15,020 | -13,645 | -15,428 |
| Other Income | 2,742 | 2,454 | 2,125 | 1,136 | 333 |
| Pre-tax Income | -13,272 | -11,880 | -12,895 | -12,509 | -15,095 |
| Net Income Continuous | -13,272 | -11,880 | -12,895 | -12,509 | -15,095 |
| Net Income | $-13,272 | $-11,880 | $-12,895 | $-12,509 | $-15,095 |
| EPS Basic Total Ops | -0.31 | -0.28 | -0.30 | -0.30 | -0.36 |
| EPS Basic Continuous Ops | -0.31 | -0.28 | -0.30 | -0.30 | -0.36 |
| EPS Diluted Total Ops | -0.31 | -0.28 | -0.30 | -0.30 | -0.36 |
| EPS Diluted Continuous Ops | -0.31 | -0.28 | -0.30 | -0.30 | -0.36 |
| EBITDA(a) | $-15,925 | $-14,251 | $-14,938 | $-13,563 | $-15,360 |